Preview Mode Links will not work in preview mode

Eagle's Eye View: Your Weekly CV Update From

Jan 17, 2018

This week's View focuses on two trials that studied interventions in patients with stable ischemic heart disease: ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina) and SENIOR (A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs. a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years).